Actively Recruiting
Study of T Cell Responses to Arbovirus Infections Using ELISpot Tests in Adults
Led by Fondazione IRCCS Policlinico San Matteo di Pavia · Updated on 2026-03-04
500
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
This research focuses on arboviruses, a group of RNA viruses spread by insects like mosquitoes, ticks, and sandflies, which can infect humans and cause serious diseases. In Italy, certain arboviruses are common, while others are monitored closely because travel and climate change may increase their spread. The study aims to examine immune responses in patients infected with these viruses to improve diagnosis and control outbreaks. The study evaluates immunological tests, specifically the ELISpot assay, to monitor T-cell responses against arboviruses. These tests are studied alongside traditional molecular and serological methods, aiming to improve diagnosis since molecular tests have limited detection windows and serological tests can cross-react between viruses. The study uses these immunological assays to better detect and understand arbovirus infections. Participants suspected of having arbovirus infections will undergo immunological testing to assess their T-cell response over up to one year. Researchers will measure how well these T-cell based assays perform in detecting arbovirus infections. The study involves collecting samples for testing and monitoring immune responses, helping to identify patients at risk and improve disease surveillance and control. Participation includes informed consent and regular follow-up evaluations.
CONDITIONS
Brief Title
ARBOspot: Characterization of Arbovirus Specific T Cell Response in Patients by Using Enzyme Linked Immunospot (ELISpot) Assays
Research Team
B
Baldanti
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here